drugset / Trial / NCT01492621

Effect of Antidepressants on White Matter Structure

NCT01492621

NaSingle-groupOpen-labelBasic science

Summary

Subjects with major depression will be evaluated and intensively characterized through questionnaires, computerized cognitive evaluation and laboratory investigations. Magnetic resonance imaging will be used to document baseline white matter structure. subjects will then receive desvenlafaxine which will be adjusted as clinically indicated. After 16 weeks the evaluations will be repeated.

Timeline

Start
2011-11
Primary completion
2013-09
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Desvenlafaxine Other / unclassified 50 mg
Subject Desvenlafaxine Other / unclassified 100 mg